Fast Market Research

Neurocrine Biosciences, Inc. - Product Pipeline Review - 2013 - New Report Available

Recently published research from Global Markets Direct, "Neurocrine Biosciences, Inc. - Product Pipeline Review - 2013", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 07/02/2013 -- Global Market Direct's pharmaceuticals report, "Neurocrine Biosciences, Inc. - Product Pipeline Review - 2013" provides data on the Neurocrine Biosciences, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Neurocrine Biosciences, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Neurocrine Biosciences, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents


- Neurocrine Biosciences, Inc. - Brief Neurocrine Biosciences, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Neurocrine Biosciences, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Neurocrine Biosciences, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neurocrine Biosciences, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Neurocrine Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neurocrine Biosciences, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neurocrine Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neurocrine Biosciences, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neurocrine Biosciences, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Neurocrine Biosciences, Inc.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Neurocrine Biosciences, Inc. - Product Pipeline Review - 2012
- Apricus Biosciences, Inc. - Product Pipeline Review - 2013
- Sangamo BioSciences, Inc. - Product Pipeline Review - 2013
- Ambit Biosciences Corporation - Product Pipeline Review - 2013
- Ardea Biosciences, Inc. - Product Pipeline Review - 2013
- Chipscreen Biosciences Ltd - Product Pipeline Review - 2013
- Dyskinesia - Pipeline Review, H1 2013
- ACE BioSciences A/S - Product Pipeline Review - 2013
- Neurocrine Biosciences, Inc. (NBIX) - Financial and Strategic SWOT Analysis Review
- Talon Therapeutics, Inc. - Product Pipeline Review - 2013